China's Stocks Lose Steam as Enthusiasm for Major Stimulus Wanes. What's Next?

Analysts NotebookOct 8 06:04 ET

Barclays Maintains Underweight on Bristol-Myers Squibb, Raises Price Target to $43

BenzingaOct 7 14:42 ET · Ratings

Reviva Pharmaceuticals Schizophrenia Drug Demonstrates Strong Efficacy On Heels Of Bristol Myers, FDA Approval: Analyst

BenzingaOct 7 14:13 ET

Unveiling 11 Analyst Insights On Bristol-Myers Squibb

BenzingaOct 7 14:00 ET

Bristol-Myers Squibb Analyst Ratings

BenzingaOct 7 13:36 ET · Ratings

10 Health Care Stocks Whale Activity In Today's Session

BenzingaOct 7 13:35 ET